Delivery Order SPE2DB22D3301-SPE2DB24FY9MP
Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $6.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of 4564313689 - LIVALO 4 MG TABLET 90S, a pharmaceutical product, at a firm fixed price of $5,287.84. The award has an ultimate completion date of April 18, 2024. The contract does not have a set-aside...
- This federal contract award, with ID SPE2DX15D3020|SPE2DX23FXHLN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,185.76 firm-fixed-price delivery order is for the supply of the pharmaceutical product LIVALO 2 MG TABLET 90S. The contract has an ultimate completion date of August 8, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,219.94 firm fixed-price delivery order is for the supply of 90 tablets of the prescription medication LIVALO 2 MG. The contract has an ultimate completion date of July 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $1,417.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of the prescription drug Livalo 1 mg tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,146.26, is for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of November 15, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,038.36, is for the supply of LIVALO 2 MG TABLET 90S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with a completion date of June 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award, valued at $2,540.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of LIVALO 2 MG TABLET 90S, a pharmaceutical product, to support military healthcare...
- This federal contract award, valued at $17,208.45, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of LIVALO 4 MG TABLET 90S, a pharmaceutical product, with a performance period ending on May 10, 2023. The contract has no set-aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.72, is a delivery order for the supply of LIVALO 4 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any set-aside...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,139.86 for the provision of Pitavastatin 2 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 2025 to...